2014
DOI: 10.3109/01443615.2014.960830
|View full text |Cite
|
Sign up to set email alerts
|

The impact of the time interval onin-vitrofertilisation success after failure of the first attempt

Abstract: The aim of this study was to identify the optimal time interval for in-vitro fertilisation that would increase treatment success after failure of the first attempt. This retrospective study evaluated 454 consecutive cycles of 227 infertile women who had two consecutive attempts within a 6-month period at an IVF centre. Data were collected on duration of stimulation, consumption of gonadotropin, numbers of retrieved oocytes, mature oocytes, fertilised eggs, good quality embryos on day 3/5 following oocyte retri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Finally, 17 studies were screened and 12 were included in the meta‐analysis. The characteristics of studies excluded 30‐34 are listed in Table S2. All the studies included scored well on the NOS, achieving a score of between 7 and 9 (Table S1).…”
Section: Resultsmentioning
confidence: 99%
“…Finally, 17 studies were screened and 12 were included in the meta‐analysis. The characteristics of studies excluded 30‐34 are listed in Table S2. All the studies included scored well on the NOS, achieving a score of between 7 and 9 (Table S1).…”
Section: Resultsmentioning
confidence: 99%
“…IVF offers personal approaches for couples according to their specific infertility problems and may include PGD, single-embryo transfer, blastocyst transfer, and optimization of uterine receptivity. 25 PGD is recommended for couples at risk for specific inherited disorders, such as α-thalassemias –SEA carriers. To the best of our knowledge, this is the first study to introduce a new, noninvasive medium-based testing to screen healthy embryos from α-thalassemias –SEA carriers who undergo IVF.…”
Section: Discussionmentioning
confidence: 99%